Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT06853769
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Anlotinib hydrochloride,Penpulimab
Sponsor
The First Affiliated Hospital with Nanjing Medical University